ストックスクリーナーアプリを入手
21.74
0.31%
0.07
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
Pacer Advisors Inc. Has $13.90 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Screener Results Flag Amphastar Pharmaceuticals Inc. as OversoldEntry Alert Based on Volume Spikes Detected - metal.it
Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More (NASDAQ:AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Victory Capital Management Inc. - MarketBeat
Q1 Earnings Highlights: Amneal, ANI, Amphastar, and ViatrisNews and Statistics - IndexBox
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025 - ACCESS Newswire
Amphastar Pharmaceuticals Schedules Q2 Earnings: Key Financial Results Coming August 7 - Stock Titan
Legato Capital Management LLC Purchases 11,238 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Is it the right time to buy Amphastar Pharmaceuticals Inc. stockSmart Portfolio Data Feed For 2025 - jammulinksnews.com
Lidocaine Vial Market Set to Witness Significant Growth by 2033 | - openPR.com
Published on: 2025-07-28 17:34:56 - metal.it
When is Amphastar Pharmaceuticals Inc. stock expected to show significant growthConsistent double returns - jammulinksnews.com
Published on: 2025-07-28 16:16:47 - metal.it
What are Amphastar Pharmaceuticals Inc. company’s key revenue driversCapitalize on market momentum for maximum gains - jammulinksnews.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by TD Asset Management Inc - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Royce & Associates LP - MarketBeat
What is Amphastar Pharmaceuticals Inc. company’s growth strategyUnlock powerful stock screening for profits - jammulinksnews.com
Should I hold or sell Amphastar Pharmaceuticals Inc. stock in 2025High-return market picks - jammulinksnews.com
Does Amphastar Pharmaceuticals Inc. stock perform well during market downturnsUnprecedented market success - jammulinksnews.com
New York State Common Retirement Fund Grows Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
What analysts say about Amphastar Pharmaceuticals Inc. stock outlookRecord-setting profit potential - jammulinksnews.com
What risks could impact Amphastar Pharmaceuticals Inc. stock performanceSkyrocketing investment returns - jammulinksnews.com
What drives Amphastar Pharmaceuticals Inc. stock priceRecord-breaking gains - PrintWeekIndia
What analysts say about Amphastar Pharmaceuticals Inc. stockHigh-yield market plays - PrintWeekIndia
Is Amphastar Pharmaceuticals (NASDAQ:AMPH) Using Too Much Debt? - 富途牛牛
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 1-Year LowWhat's Next? - MarketBeat
Amphastar Pharmaceuticals Inc. Stock Analysis and ForecastPhenomenal capital gains - jammulinksnews.com
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know - Barchart.com
What Makes Amphastar (AMPH) a New Buy Stock - Yahoo Finance
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock? - Yahoo Finance
Here's Why Amphastar (AMPH) is Poised for a Turnaround After Losing 13.1% in 4 Weeks - Yahoo Finance
Is Amphastar Pharmaceuticals Inc. a good long term investmentFree Market Volatility Navigation Tips - jammulinksnews.com
Hussman Strategic Advisors Inc. Acquires Shares of 31,500 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Hypoglycemia Pipeline 2025: Key Companies, MOA, ROA, - openPR.com
0.08%
1.47%
大文字化:
|
ボリューム (24 時間):